ylliX - Online Advertising Network
Company Ticker News

Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays

Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

An analyst at BofA Securities on Wednesday shared a pair trade idea in the large-cap pharma space. The Biopharma Analyst: Geoff Meacham upgraded Pfizer, Inc. (NYSE:PFE) shares from Neutral to Buy and increased the price target from $59 to $70.

...read full article on Benzinga

ylliX - Online Advertising Network